Literature DB >> 12845236

Accelerated progression of calcific aortic stenosis in dialysis patients.

Vlado Perkovic1, David Hunt, Sian V Griffin, Moira du Plessis, Gavin J Becker.   

Abstract

BACKGROUND: Abnormalities of the aortic valve occur with increased frequency in patients with renal failure and may contribute to the observed excess cardiovascular mortality. Little data exist on the rate at which aortic stenosis progresses in this patient group.
METHODS: A retrospective case-control study was designed to compare the rate of progression of aortic stenosis in dialysis patients with that in sex-matched controls. Dialysis patients with aortic stenosis were identified by a search of the echocardiography database. Twenty-eight dialysis patients were compared to 56 sex-matched controls, all of whom had aortic stenosis on at least two echocardiograms 6 months apart. Changes in mean and peak transvalvular gradient as well as valve area were calculated from echocardiographic data and compared.
RESULTS: Aortic stenosis progressed more rapidly in the dialysis patients than in the controls when measured by change in valve area (-0.19 vs. -0.07 cm2/year; p < 0.001) and change in peak transvalvular gradient (6.5 vs. 3.9 mm Hg/ year; p = 0.04). There was also a trend towards more rapid progression of mean transvalvular gradient (4.9 vs. 2.5 mm Hg/year; p = 0.052). On multivariate linear regression analysis, only end-stage renal failure (p = 0.02) and baseline valve area (p = 0.04) predicted accelerated progression of aortic stenosis.
CONCLUSIONS: Aortic stenosis progressed more rapidly in the presence of renal failure. The time frames for review and operation in dialysis patients should be shorter than for the general population. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12845236     DOI: 10.1159/000071280

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  23 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study.

Authors:  Gry Wisthus Eveborn; Henrik Schirmer; Per Lunde; Geir Heggelund; John-Bjarne Hansen; Knut Rasmussen
Journal:  Eur J Epidemiol       Date:  2014-07-15       Impact factor: 8.082

3.  Higher visit-to-visit intra-dialytic blood pressure is associated with the progression of aortic valve stenosis in chronic hemodialysis patients.

Authors:  Naoki Norioka; Shinichi Iwata; Shiro Yanagi; Hideshi Ishii; Kenichi Sugioka; Kimio Kamimori; Takahiro Ota; Marco R Di Tullio; Shunichi Homma; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2015-10-05       Impact factor: 2.037

Review 4.  Diagnosis and management of patients with asymptomatic severe aortic stenosis.

Authors:  Minako Katayama; Hari P Chaliki
Journal:  World J Cardiol       Date:  2016-02-26

5.  Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease.

Authors:  Lei Zhang; Shaoyan Yang; Jianling Chen; Jinling Ma; Yueqin Ren
Journal:  Int Urol Nephrol       Date:  2017-02-27       Impact factor: 2.370

Review 6.  Management of cardiovascular disease in patients with kidney disease.

Authors:  Mark R Kahn; Michael J Robbins; Michael C Kim; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2013-02-19       Impact factor: 32.419

Review 7.  Risk factors for valvular calcification.

Authors:  Hao Yu Chen; James C Engert; George Thanassoulis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-04       Impact factor: 3.243

8.  Parathyroidectomy and heart rate variability in patients with stage 5 CKD.

Authors:  Jing Zhang; Xiangbao Yu; Bin Sun; Jianling Bai; Yongyue Wei; Xiaoming Zha; Yiyao Cui; Ming Zeng; Jingjing Zhang; Jia Liu; Huijuan Mao; Bo Zhang; Haibin Ren; Yifei Ge; Xueqiang Xu; Zhixiang Shen; Changying Xing; Kejiang Cao; Ningning Wang
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

Review 9.  Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease.

Authors:  Z A Massy; C Mazière; S Kamel; M Brazier; G Choukroun; C Tribouilloy; M Slama; M Andrejak; J C Mazière
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

10.  ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.

Authors:  Mikko A Simolin; Tanja X Pedersen; Susanne Bro; Mikko I Mäyränpää; Satu Helske; Lars B Nielsen; Petri T Kovanen
Journal:  BMC Cardiovasc Disord       Date:  2009-03-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.